Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Overexpression of a Mycobacterium ulcerans Ag85B-EsxH Fusion Protein in Recombinant BCG Improves Experimental Buruli Ulcer Vaccine Efficacy.

Hart BE, Lee S.

PLoS Negl Trop Dis. 2016 Dec 12;10(12):e0005229. doi: 10.1371/journal.pntd.0005229. eCollection 2016 Dec.

2.

PD-1 Expression and Cytokine Secretion Profiles of Mycobacterium tuberculosis-Specific CD4+ T-Cell Subsets; Potential Correlates of Containment in HIV-TB Co-Infection.

Pollock KM, Montamat-Sicotte DJ, Grass L, Cooke GS, Kapembwa MS, Kon OM, Sampson RD, Taylor GP, Lalvani A.

PLoS One. 2016 Jan 12;11(1):e0146905. doi: 10.1371/journal.pone.0146905. eCollection 2016.

3.

Differences in antigen-specific CD4+ responses to opportunistic infections in HIV infection.

Pollock KM, Montamat-Sicotte DJ, Cooke GS, Kapembwa MS, Kon OM, Grass L, Sampson RD, Taylor GP, Lalvani A.

Immun Inflamm Dis. 2015 Sep;3(3):141-53. doi: 10.1002/iid3.50. Epub 2015 Apr 29.

4.

The within host dynamics of Mycobacterium avium ssp. paratuberculosis infection in cattle: where time and place matter.

Koets AP, Eda S, Sreevatsan S.

Vet Res. 2015 Jun 19;46:61. doi: 10.1186/s13567-015-0185-0. Review.

5.

Specific in vitro interferon-gamma and IL-2 production as biomarkers during treatment of chronic Q fever.

Schoffelen T, Wegdam-Blans MC, Ammerdorffer A, Pronk MJ, Soethoudt YE, Netea MG, van der Meer JW, Bleeker-Rovers CP, van Deuren M.

Front Microbiol. 2015 Feb 12;6:93. doi: 10.3389/fmicb.2015.00093. eCollection 2015.

6.
7.

Reduced frequency of memory T cells and increased Th17 responses in patients with active tuberculosis.

Marín ND, París SC, Rojas M, García LF.

Clin Vaccine Immunol. 2012 Oct;19(10):1667-76. Epub 2012 Aug 22.

8.

Transcriptional profiling of disease-induced host responses in bovine tuberculosis and the identification of potential diagnostic biomarkers.

Aranday-Cortes E, Hogarth PJ, Kaveh DA, Whelan AO, Villarreal-Ramos B, Lalvani A, Vordermeier HM.

PLoS One. 2012;7(2):e30626. doi: 10.1371/journal.pone.0030626. Epub 2012 Feb 16.

9.

Diagnosing latent tuberculosis in high-risk individuals: rising to the challenge in high-burden areas.

Kasprowicz VO, Churchyard G, Lawn SD, Squire SB, Lalvani A.

J Infect Dis. 2011 Nov 15;204 Suppl 4:S1168-78. doi: 10.1093/infdis/jir449. Review.

10.

Mycobacterial PE/PPE proteins at the host-pathogen interface.

Sampson SL.

Clin Dev Immunol. 2011;2011:497203. doi: 10.1155/2011/497203. Epub 2011 Jan 26. Review.

11.

Enumeration of functional T-cell subsets by fluorescence-immunospot defines signatures of pathogen burden in tuberculosis.

Casey R, Blumenkrantz D, Millington K, Montamat-Sicotte D, Kon OM, Wickremasinghe M, Bremang S, Magtoto M, Sridhar S, Connell D, Lalvani A.

PLoS One. 2010 Dec 14;5(12):e15619. doi: 10.1371/journal.pone.0015619.

12.

Production of TNF-alpha, IL-12(p40) and IL-17 can discriminate between active TB disease and latent infection in a West African cohort.

Sutherland JS, de Jong BC, Jeffries DJ, Adetifa IM, Ota MO.

PLoS One. 2010 Aug 24;5(8):e12365. doi: 10.1371/journal.pone.0012365.

13.

Immunogenicity of novel DosR regulon-encoded candidate antigens of Mycobacterium tuberculosis in three high-burden populations in Africa.

Black GF, Thiel BA, Ota MO, Parida SK, Adegbola R, Boom WH, Dockrell HM, Franken KL, Friggen AH, Hill PC, Klein MR, Lalor MK, Mayanja H, Schoolnik G, Stanley K, Weldingh K, Kaufmann SH, Walzl G, Ottenhoff TH; GCGH Biomarkers for TB Consortium.

Clin Vaccine Immunol. 2009 Aug;16(8):1203-12. doi: 10.1128/CVI.00111-09. Epub 2009 Jun 24.

14.

Screening for tuberculosis infection prior to initiation of anti-TNF therapy.

Lalvani A, Millington KA.

Autoimmun Rev. 2008 Dec;8(2):147-52. doi: 10.1016/j.autrev.2008.07.011. Epub 2008 Aug 13. Review.

Supplemental Content

Support Center